Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Larger individuals may need higher doses to achieve equivalent therapeutic effects
A pharmaceutical company sponsors a drug through preclinical testing, Phase 1 (safety), Phase 2 (dosing and efficacy), and Phase 3 (large-scale efficacy) clinical trials
The study was approved by the Institutional Review Board at the University of Kansas Medical Center (KUMC, Kansas City, KS, United States) and registered at www.ClinicalTrials.gov as NCT02957422
Like the homogenates, PEGDA:GSH microspheres exhibited affinity to GST-GFP and can be used to purify the protein
US$ 28.52
US$ 22.02
US$ 21.34
US$ 29.67
US$ 22.80
US$ 26.94
US$ 28.24
